News Express: UM Centre for Innovation and Entrepreneurship holds first expert committee meeting to discuss ‘big health+’
新聞快訊：澳大創新創業中心首屆專家委員會會議聚焦“大健康+”
澳大創新創業中心舉行首屆專家委員會會議
The UM Centre for Innovation and Entrepreneurship holds its first expert committee meeting
澳大創新創業中心首屆專家委員會會議聚焦“大健康+”
在澳門科學技術發展基金資助下成立的“澳門大學創新創業中心（國家級眾創空間）”轉化平台舉行首屆專家委員會會議。會議重點圍繞該平台打造的澳大大健康科技創新加速器（簡稱“大健康+”加速器）計劃進行研討，與會委員對加速器的定位與建設給予高度評價，並就未來的發展策略與成果轉化路徑，提供了多項建設性建議。
澳門科學技術發展基金行政委員會委員葉桂林、澳大副校長徐建、專家委員會主席艾荃分別致歡迎辭。會議由澳大創新創業中心執行主任兼健康科學學院教授梁麗嫻主持。梁麗嫻匯報了澳大創新創業中心的工作概況及最新進展，並指出“大健康+”加速器是澳門首個專注於大健康領域的轉化加速平台，旨在系統性推動琴澳兩地在大健康領域的優質科研成果轉化，透過概念驗證與市場對接，助力項目跨越從實驗室到商業化的“死亡之谷”，並為創業團隊搭建資源與投資平台。各委員及專家學者對加速器的發展方向進行深入探討，並提出了多項優化策略，為加速器的後續實施與持續發展奠定了堅實的基礎。
首屆專家委員會匯聚產、學、研、醫、投領域的專家，參與的委員包括：Macafex諮詢公司總裁馮文昌、世界頂尖科學家協會聯合創始人吳澤強、澳門藥廠商會會長蔡建華、杭州泰格醫藥科技股份有限公司副總裁黃鑫、深圳華大生命科學研究院副院長方曉東、澳大藥品監管科學研究中心主任兼中華醫藥研究院教授胡元佳、澳門鏡湖醫院副院長謝學斌、粵澳合作中醫藥科技產業園董事長吳松，以及中金資本運營有限公司董事總經理兼橫琴引導基金負責人許中超。澳門科學技術發展基金科技發展及合作部高級技術員林振誠和澳大中華醫藥研究院院長陳新亦一同列席參會。
欲瀏覽官網版可登入以下連結:
https://www.um.edu.mo/zh-hant/news-and-press-releases/press-release/detail/62862/
UM Centre for Innovation and Entrepreneurship holds first expert committee meeting to discuss ‘big health+’
The Centre for Innovation and Entrepreneurship (CIE) of the University of Macau (UM), a national co-working space and a research translation platform funded by the Macao Science and Technology Development Fund (FDCT), held its first expert committee meeting. The meeting focused on CIE’s newly launched ‘Health+’ Accelerator Programme, an initiative designed to promote technology transfer and innovation in the ‘big health’ sector. Committee members spoke highly of the programme’s direction and progress, and provided suggestions on future strategies and ways to translate related research outcomes into real-world applications.
The meeting was chaired by Leung Lai Han, head of CIE and professor in the UM Faculty of Health Sciences, with opening remarks delivered by Ip Kuai Lam, member of the Administrative Committee of FDCT; Xu Jian, vice rector of UM; and David Ai, chairman of the expert committee. Leung presented an overview of CIE’s work and recent progress. She highlighted that the ‘Health+’ Accelerator Programme—Macao’s first accelerator dedicated to the ‘big health’ sector—aims to systematically advance the transformation of high-quality ‘big health’ research achievements in Macao and Hengqin. By supporting proof-of-concept development and market alignment, the programme helps projects bridge the ‘valley of death’ between laboratory research and commercialisation, while building resource and investment platforms for start-ups. Committee members and experts engaged in in-depth discussions on the accelerator’s development direction and provided strategies for further improvement, laying a solid foundation for its future implementation and sustainable development.
The first expert committee brings together experts across the industry, academic, research, healthcare, and investment sectors. Members include: Mann Fung, president of Macafex Consulting LLC; Chuck Ng, co-founder of the World Leading Scientists Institute; Choi Kin Wa, president of the Association of Macao Pharmaceutic Products Manufacturer; Huang Xin, vice president of Hangzhou Tigermed Consulting Co., Ltd.; Fang Xiaodong, vice president of BGI Research; Hu Yuanjia, director of the Centre for Pharmaceutical Regulatory Sciences and professor in the Institute of Chinese Medical Sciences (ICMS) at UM; Xie Xuebin, deputy director of Kiang Wu Hospital; Wu Song, chairman of the Traditional Chinese Medicine Science and Technology Industrial Park of Co-operation between Guangdong and Macao; and Xu Zhongchao, managing director of CICC Capital and head of the Hengqin Guidance Fund. Lam Chan Seng, senior administrative officer of the Science and Technology Development and Cooperation Department of FDCT; and Chen Xin, director of UM ICMS, also attended the meeting.
To read the news on UM’s official website, please visit the following link:
https://www.um.edu.mo/news-and-press-releases/press-release/detail/62862/